A reasonable chance it could cause serious harm or death.
Presence of Particulate Matter
| Brand name | ROPIVACAINE HYDROCHLORIDE |
| Generic name | ROPIVACAINE HYDROCHLORIDE |
| Active ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Distributed by / for | Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 |
| NDC | 70121-1734-1 |
| Full product label | Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box) |
| Recalling firm | Amneal Pharmaceuticals, LLC |
| Distribution | Nationwide in the US |
| Quantity | 62 (12x100mL) bags |
| Recall initiated | 2025-04-17 |
| Report date | 2025-05-14 |
| Recall completed | — |
| Recall number | D-0402-2025 |
| Classification | Class I |
| FDA status | Ongoing |
| Origin on file | Bridgewater NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗